• Doctors know that a much smaller number of people with GD can develop multiple myeloma, a malignancy of bone marrow plasma cells. (gaucherdisease.org)
  • Multiple myeloma (also known as MM , myeloma , plasma cell myeloma , or as Kahler's disease after Otto Kahler) is a presently incurable hematological malignancy of plasma cells, the cells of the immune system that produce antibodies. (the-medical-dictionary.com)
  • Multiple myeloma, a rare malignancy of plasma cells, was first described in 1950 as an abnormal production of immunoglobulins. (the-medical-dictionary.com)
  • A chromosomal aberration involving CCND1 may be a cause of B-lymphocytic malignancy, particularly mantle-cell lymphoma (MCL). (enquirebio.com)
  • Innovations in immunotherapy have led to the development of multiple immune-targeted therapies to manage malignancy. (ajmc.com)
  • A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. (lookformedical.com)
  • Multiple myeloma (MM) is the second most common hematologic malignancy and remains incurable despite the advent of numerous new drugs such as proteasome inhibitors (PIs), immunomodulatory agents (IMiDs), and monoclonal antibodies. (biomedcentral.com)
  • Multiple myeloma (MM) is a hematological malignancy characterized by the proliferation of transformed monoclonal plasma cells in the bone marrow (BM) [ 1 ]. (biomedcentral.com)
  • OPINION STATEMENT: Mantle cell lymphoma (MCL) treatment advances have significantly improved disease-free remission, with greater focus in clinical trials being placed on measurable residual disease (MRD) as a marker of subclinical disease assessment. (bvsalud.org)
  • 1 B cell neoplasms other than multiple myeloma including non-Hodgkin's lymphomas, and acute and chronic leukaemias might also exhibit lytic bone lesions, hypercalcaemia, and monoclonal gammopathy via the particular actions of interleukin (IL-1), IL-6, or tumour necrosis factor-α secreted by the neoplastic B cell clone, but not reported previously secondary to a primary cerebral lymphoma. (bmj.com)
  • 2 We describe an unusual presentation of a B cell primary cerebral lymphoma mimicking a plasma cell dyscrasia. (bmj.com)
  • Total excision of the lesion disclosed large lymphocytes with oval and vesicular nuclei, and prominent nucleoli consistent with "intermediate grade large cell malignant lymphoma" according to the working formulation. (bmj.com)
  • Staining with CD10 was also positive confirming the diagnosis of B cell lymphoma. (bmj.com)
  • This type of amyloid is usually associated with systemic disease due to an underlying clonal plasma cell proliferative disorder or a B-cell lymphoma. (contemporaryobgyn.net)
  • Cyclin D1 is also known as BCL1, B Cell Lymphoma #1, CCND1. (enquirebio.com)
  • Abstract B38: FOXP1 truncated isoforms differentially regulate target genes in diffuse large B cell lymphoma. (growkudos.com)
  • Chimeric antigen receptor (CAR) T-cell therapy is an example of how immunotherapy is revolutionizing the treatment of hematologic malignancies with unprecedented response rates in patients with relapsed/refractory lymphoma, multiple myeloma, and acute lymphoblastic leukemia. (ajmc.com)
  • Managed care professionals should have an understanding of the clinical trial data and place in therapy in lymphoma, myeloma, and acute lymphoblastic leukemia as well as guideline recommendations for adverse effect management associated with CAR T-cell therapies. (ajmc.com)
  • The image below shows pre-B-cell lymphoblastic leukemia/lymphoma (B-ALL). (medscape.com)
  • Aberrant activation of CAMKIIγ has been linked to leukemia and T-cell lymphoma, but not multiple myeloma (MM). The purpose of this study was to explore the role of CaMKIIγ in the pathogenesis and therapy of MM. In this study, we found that CaMKIIγ was aberrantly activated in human MM and its expression level was positively correlated with malignant progression and poor prognosis. (aging-us.com)
  • Moreover, we found that CAMKIIγ is a critical regulator of MYC protein stability in human T-cell lymphoma [ 9 ]. (aging-us.com)
  • In addition, we demonstrated that the natural compound berbamine (BBM) is a CAMKIIγ inhibitor and potently inhibits T-cell lymphoma growth in mouse model [ 9 ]. (aging-us.com)
  • Lymphoma is a cancer that starts in cells that are part of the body's immune system. (invivoscribe.com)
  • Venetoclax is active in other lymphoid malignancies including several B cell non-Hodgkin lymphomas, acute lymphoblastic leukemia and multiple myeloma, with the highest intrinsic sensitivity observed in mantle cell lymphoma and Waldenstrom macroglobulinemia. (biomedcentral.com)
  • Venetoclax combination with standard regimens in follicular lymphoma, multiple myeloma and aggressive B cell neoplasms has shown some promise, but further studies are required to optimize dose and scheduling to mitigate increased myelosuppression and infection risk, and to find validated biomarkers of venetoclax sensitivity. (biomedcentral.com)
  • Initially identified as the fusion partner of the immunoglobulin heavy chain gene locus in the classic t(14;18) translocation of follicular lymphoma (FL), BCL2 overexpression was recognized to confer resistance to apoptosis [ 2 ]. (biomedcentral.com)
  • Macroglobulinemia is a malignant plasma cell disorder in which B cells produce excessive amounts of IgM M-proteins. (merckmanuals.com)
  • Excessive amounts of IgM M-proteins (monoclonal immunoglobulin protein, which may consist of both heavy and light chains or of only one type of chain) can also accumulate in other disorders, causing manifestations similar to macroglobulinemia. (merckmanuals.com)
  • Less commonly, patients develop hyperviscosity due to the large amounts of high molecular weight monoclonal IgM proteins circulating in plasma, but most patients do not develop problems related to high IgM levels. (merckmanuals.com)
  • The filtered light-chain proteins, reabsorbed by the proximal tubular cells via the tandem megalin/cubilin receptors, are catabolized by lysosomal enzymes. (medscape.com)
  • Metabolism (catabolism) of these filtered light-chain proteins depends on normal proximal tubular cell function, and damage to these cells can result in increased excretion of light-chain proteins in the urine. (medscape.com)
  • Amyloidosis is a term used to describe fibril deposition of proteins.AL amyloidosis is due to deposition of protein from immunoglobulin light chain fragments. (contemporaryobgyn.net)
  • Plasma cell myeloma (multiple myeloma, myelomatosis, medullary plasmacytoma) is a bone marrow-based, malignant disorder of postgerminal center B-cells that is characterized by a clonal proliferation of plasma cells, with associated serum and/or urine monoclonal proteins. (medscape.com)
  • We will also look at the combination of mAbs with immunostimulants such as GMCSF and IL-2 (fusion proteins) and eventual conjugation of the mAbs with alpha and possibly B -emitters to help in targeting bystander cells. (jcancer.org)
  • It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. (lookformedical.com)
  • Changes in glycan structures and the interactions of these structures with endogenous carbohydrate- binding proteins, known as lectins, are now considered to be potential biomarkers on cancer cells for monitoring tu- mor progression. (fdocuments.net)
  • The traditional triad in the medical diagnosis of multiple myeloma may be the recognition of M proteins in the serum or urine (Bence-Jones proteins), higher than 10% plasmacytosis in the bone tissue marrow, and the current presence of osteolytic lesions by radiography. (siamtech.net)
  • BH3-mimetics are a novel drug class of small molecule inhibitors of BCL2 family proteins which restore apoptosis in malignant cells. (biomedcentral.com)
  • In brief, apoptosis is triggered when "pro-death/damage sensing" BH3-only proteins activate the downstream effector molecules BAX and BAK, which dimerize on the mitochondrial outer membrane surface and permeabilize it, triggering the release of cytochrome C, caspase activation and committing the cell to programmed death. (biomedcentral.com)
  • 1) It accounts for approximately 10 to 15% of all hematologic malignancies, 1% of all malignant neoplasms in whites and 2% in blacks, and 2% of deaths from all malignancies. (the-medical-dictionary.com)
  • It is a putative proto-oncogene overexpressed in a wide variety of human neoplasms including mantle cell lymphomas (MCL). (enquirebio.com)
  • The etiology of plasma cell neoplasms is unknown in the majority of cases. (medscape.com)
  • Solitary plasmacytoma of bone comprises 3-5% of all plasma cell neoplasms. (medscape.com)
  • Plasma cell neoplasms show a spectrum of disease from asymptomatic to symptomatic forms. (medscape.com)
  • Paraproteinaemia is a disorder characterized by abnormal proliferation of immunoglobulin-producing cells due to the neoplastic behavior of B-Lymphocytic series with an increase in serum level of homogenous immunoglobulin (monoclonal IG) or its fragments. (emedicodiary.com)
  • Paraprotein is the presence of a monoclonal immunoglobulin band (M-band) in the serum. (emedicodiary.com)
  • Diagnosis typically requires demonstration of M-protein (sometimes present in urine and not serum but rarely absent entirely) and/or light-chain proteinuria, and excessive plasma cells in the bone marrow. (merckmanuals.com)
  • The EdU reagent was diluted to 20?M in serum-free medium, added to the cells and incubated for 4?h. (healthanddietblog.info)
  • This abnormal monoclonal immunoglobulin (Ig) is present in the serum, CSF, and urine. (labpedia.net)
  • Multiple myelomas show in 99 % of the patients in serum and urine. (labpedia.net)
  • Clinical improvement was paralleled by a strong reduction in serum ANCA levels as well as total IgG, indicating depletion of plasma cells. (bmj.com)
  • Asymptomatic plasma cell myeloma is a plasma cell neoplasm defined by the presence of serum monoclonal protein of 3.0 gm/dL or greater (by electrophoresis) and/or clonal plasma cells in the bone marrow of 10% or greater, without evidence of end-organ damage (hypercalcemia, renal insufficiency, anemia, lytic lesions of bone). (medscape.com)
  • Conditions characterized by the presence of M protein (Monoclonal protein) in serum or urine without clinical manifestations of plasma cell dyscrasia. (lookformedical.com)
  • In normal serum, SPEP yields a broad gamma fraction with Gaussian distribution due to the millions of plasma cell clones that secrete immunoglobulins into the serum. (degruyter.com)
  • Oddly enough, the serum MCP-1 Metoclopramide HCl level elevated and peaked at six h after c-lipo pretreatment quickly, suggesting which the MCP-1 made by c-lipo-phagocytized Compact disc68+ Kupffer cells Metoclopramide HCl may recruit Compact disc11b+ macrophages in the periphery and bone tissue marrow. (enmd-2076.com)
  • A polyclonal immunoglobulin pattern in the serum or urine immunofixation is considered to be nonspecific. (medscape.com)
  • The presence of oligoclonal bands in CSF but not in the serum, given their intrathecal production, is helpful in the diagnosis of multiple sclerosis. (medscape.com)
  • Plasma cells normally produce a slight excess of light chains that are either excreted or catabolized by the kidney, and only a minute amount of light-chain protein normally appears in the urine. (medscape.com)
  • The term Bence Jones protein has been used to designate a urinary protein that leaves solution at approximately 56°C under certain conditions of pH and ionic strength and returns to the solution upon further heating to 100°C. The Bence Jones protein represents a homogeneous population of immunoglobulin light chains of either kappa type or lambda type and is the product of a presumed single clone of plasma cells. (medscape.com)
  • Disorders characterized by abnormal proliferation of immunoglobulin-producing cells and abnormal proliferation of immunoglobulin monoclonal (M protein)represent part of the spectrum of disease due to the neoplastic behavior of the B lymphocyte series. (emedicodiary.com)
  • In 15 to 20% of patients, plasma cells secrete only Bence Jones protein. (merckmanuals.com)
  • These substances can create a clone of plasma cells that react against specific lipids (complex fat molecules) in the body, against saposin protein, or both. (gaucherdisease.org)
  • Immunofixation electrophoresis studies will differentiate protein antigens and their split products and the evaluation of myeloma. (labpedia.net)
  • Monoclonal light chains also called κ or Bence Jones protein, are seen in the urine of Multiple myeloma cases in 75 % of the patients. (labpedia.net)
  • Cyclin D1 or PRAD-1 or bcl-1 is one of the key cell cycle regulators, and functions in association with cdk4 and/or cdk6 by phosphorylating the Rb protein. (enquirebio.com)
  • Recent studies have demonstrated that pharmacological inhibition of the Notch pathway with γ-secretase inhibitor (GSI) induces apoptosis of multiple myeloma (MM) cells via upregulation of the proapoptotic protein Noxa. (aacrjournals.org)
  • Symptomatic plasma cell myeloma is a plasma cell neoplasm defined as the presence of end-organ damage (hypercalcemia, renal insufficiency, anemia, lytic lesions of bone) in a patient with a monoclonal protein (of any amount) and clonal plasma cells in the bone marrow (of any amount) or plasmacytoma. (medscape.com)
  • An abnormal protein with unusual thermosolubility characteristics that is found in the urine of patients with MULTIPLE MYELOMA. (lookformedical.com)
  • Founded on the secretion of a monoclonal immunoglobulin (M-protein), plasma cell proliferative disorders are classified as monoclonal gammopathies and include multiple myeloma (MM), Waldenström's macroglobulinemia (WM), amyloidosis (AL), light chain deposition disease (LCDD), POEMS syndrome, and premalignant diseases such as monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM). (degruyter.com)
  • CD47 belongs to the immunoglobulin superfamily [1] and partners with membrane integrins and also binds the ligands thrombospondin-1 ( TSP-1 ) and signal-regulatory protein alpha ( SIRPα ). (wikidoc.org)
  • CD47 interacts with signal-regulatory protein alpha (SIRPα), an inhibitory transmembrane receptor present on myeloid cells . (wikidoc.org)
  • For several reasons there is a growing interest in the scientific community in immunoglobulin Y as antibiotic alternative and their oral administration in the polyclonal antibody (pAb) format, to maintain animal health and performance, do not require IgY purification for large-scale production, resulting in protein impurities and high concentration of biotin in the samples. (preprints.org)
  • This importance is focussed on the target binding site - epitope, where epitope selection as a part of design thinking beyond traditional antigen selection using whole cell or whole protein immunisation can positively impact success. (preprints.org)
  • Subsequently, several groups identified new members of the galectin family in protein extracts obtained from various tissues by using their ability to bind galactose residues on rabbit erythrocytes and cloning approaches based on sequence homology. (fdocuments.net)
  • Chimeric antigen receptor (CAR) T cell therapy has emerged as a novel immunotherapy which modifies T cells with CAR, an artificial fusion protein that incorporates an extracellular antigen recognition domain, a transmembrane domain, and an intracellular domain including costimulation and signaling components [ 4 , 5 ]. (biomedcentral.com)
  • a novel epstein-barr virus-latent membrane protein-1-specific t-cell receptor for tcr gene therapy. (liverpool.ac.uk)
  • here, we describe a tcr gene transfer regimen to rapidly and reliably generate t-cells specific to ebv-encoded latent membrane protein-1 (lmp1), which is a potential target for t-cell-based immunotherapy. (liverpool.ac.uk)
  • Immunofixation can either reveal a normal pattern or identify a monoclonal protein or a polyclonal immunoglobulin pattern. (medscape.com)
  • These data suggest the energy of the KISS1R like a novel biomarker for multiple myeloma, capable of focusing on both tumor cells and sponsor cells of the tumor microenvironment. (onlycoloncancer.com)
  • Background The peculiar multiple myeloma microenvironment, characterized by up-regulated levels of several inflammatory chemokines, including the CXCR3 receptor ligands CXCL9 and CXCL10, limits NK cell positioning into the bone marrow by interfering with CXCR4 function. (bmj.com)
  • Over the last decade, significant investigation in the MM field has demonstrated that the interaction of malignant PCs with BM stromal cells within the microenvironment is essential for survival of the PC clone [ 5 , 6 ]. (oncotarget.com)
  • The observation of this intercellular communication and that MM cells modify the microenvironment is highly suggestive that one of the first biologically relevant changes necessary for progression of MGUS or SMM to MM is for a member(s) of the clone to evolve and acquire the molecular changes needed to reprogram its immediate microenvironment into a supportive, growth-promoting microenvironment. (oncotarget.com)
  • However, the tumour may evade immune responses through regulatory T-cell-mediated immune suppression in the tumour microenvironment, defective antigen presentation, and production of immunosuppressive cytokines (5). (cambridgemedicine.org)
  • Direct skull radiography disclosed multiple lytic lesions (fig 2 ). (bmj.com)
  • Direct lateral radiography of the skull of the patient, showing multiple punched out lytic lesions of the cranial vault, with no evidence of a periosteal reaction. (bmj.com)
  • The lesions required multiple cautious passes with laser and subsequent cautery. (contemporaryobgyn.net)
  • Lesions are caused by bone replacement by expanding plasmacytomas or by cytokines that are secreted by malignant plasma cells that activate osteoclasts and suppress osteoblasts, leading to bone loss. (merckmanuals.com)
  • myeloma bone lesions. (onlycoloncancer.com)
  • Plasma cell lesions are the neoplastic (clonal) proliferation of plasma cells involving single bones (plasmacytoma) or multiple bones (multiple myeloma). (medscape.com)
  • In either form of plasma cell myeloma, immune dysfunction, cytopenias and lytic bone lesions occur as a result of direct cellular interactions (cytokines, growth factors) and/or mass effect. (medscape.com)
  • Plasma cell myeloma presents with generalized marrow involvement, with or without lytic lesions of bone. (medscape.com)
  • These lesions are uncommon in the comparative mind and throat, however when they take place, they present as huge multicystic regions of bone tissue rarefaction radiographically, which is unlike the well-defined and small destructive bone lesions of multiple myeloma. (siamtech.net)
  • It really is present as multiple lesions in 10 to 20% of situations, as well as the tumor might bargain the pleura, mediastinum, spermatic cable, ovary, intestine, kidney, pancreas, lung, and epidermis as well as the submucosa from the airways7. (siamtech.net)
  • A cell line derived from cultured tumor cells. (lookformedical.com)
  • Signaling through the receptor/transcriptional regulator Notch plays an important role in the survival of tumor cells and their protection from apoptosis induced by chemotherapeutic agents. (aacrjournals.org)
  • There is a growing literature that tumor cells release biologically active microvesicles (MVs) that modify both local and distant microenvironments. (oncotarget.com)
  • CD47 is ubiquitously expressed in human cells and has been found to be overexpressed in many different tumor cells. (wikidoc.org)
  • Oncolytic viruses (OVs) specifically induce cancer cells death by infection of and spreading on tumor cells through different mechanisms such as direct lysis effect or adjacent cells fusion. (biomedcentral.com)
  • The ability of OVs to selectively infect tumor cells is mainly associated with the disruption of type-I interferon pathway, which represents the first line of defense against viral infections. (biomedcentral.com)
  • On the other hand, the proliferation of oncolytic viruses into target cells and subsequent recognition of viral elements by pattern recognition receptors (PRRs) such as toll-like receptors can positively affect the development of the innate and adaptive immune responses against tumor cells (Fig. 1 ) [ 6 ]. (biomedcentral.com)
  • Schematic illustration of the multimodality role of virotheranostics in treatment and tracking of tumor cells. (biomedcentral.com)
  • Non-Hodgkin Lymphomas Non-Hodgkin lymphomas are a heterogeneous group of disorders involving malignant monoclonal proliferation of lymphoid cells in lymphoreticular sites, including lymph nodes, bone marrow, the. (merckmanuals.com)
  • They show that plasma cells from patients with light-chain amyloidosis (AL) most closely resemble secondary lymphoid organ plasma cells (SLO-PCs), whereas multiple myeloma (MM) cells are closer to peripheral blood plasma cells (PB-PCs) and newborn bone marrow plasma cells (BM-PCs). (ashpublications.org)
  • Acute lymphoblastic leukemia (acute lymphocytic leukemia, ALL) is a malignant (clonal) disease of the bone marrow in which early lymphoid precursors proliferate and replace the normal hematopoietic cells of the marrow. (medscape.com)
  • The malignant cells of ALL are lymphoid precursor cells (ie, lymphoblasts) that are arrested in an early stage of development. (medscape.com)
  • Expression of galectins in normal lymphoid cells Each member of the galectin family exhibits a specific expression pattern in distinct tissues, and galectin expression is regulated during development. (fdocuments.net)
  • Chronic Lymphocytic Leukemia (CLL) Chronic lymphocytic leukemia (CLL) is characterized by progressive accumulation of phenotypically mature malignant B lymphocytes. (merckmanuals.com)
  • These atypical B-lymphocytes are single clones of the proliferating cells that will produce single immunoglobulin (Ig) or its fragments. (labpedia.net)
  • solid course="kwd-title" Keywords: plasmacytoma, nasal area, sinusitis Launch Plasma cells are older B lymphocytes typically within high or low volume in various tissue and organs and in inflammatory foci generally. (siamtech.net)
  • Upon the stage of tumorigenesis, down-regulation of the major histocompatibility complex class-I (MHC-I) molecules and also the overexpression of the stress-induced ligands on the surface of malignant cells to avoid recognition by cytotoxic T-lymphocytes (CTLs), make them more sensitive to NK cell-mediated death. (biomedcentral.com)
  • Why is amyloidosis not multiple myeloma? (ashpublications.org)
  • 3 The same Navarra team and others have recently shown that the genomic landscape of AL is characterized by the same heterogeneity as that of MM. None of the few differences observed in terms of mutations and copy number abnormalities were sufficient to explain the clinical presentation of amyloidosis, suggesting that the explanation may not lie in the biology of the tumor plasma cell. (ashpublications.org)
  • After myeloma, macroglobulinemia is the 2nd most common malignant disorder associated with a monoclonal gammopathy. (merckmanuals.com)
  • Multiple myeloma is part of a spectrum of diseases ranging from monoclonal gammopathy of unknown significance (MGUS) to plasma cell leukemia. (enquirebio.com)
  • Monoclonal gammopathy of undetermined significance (MGUS) is a premalignant hematological condition arising from B‑cells, characterized by the presence of monoclonal immunoglobulin production, also known as paraprotein. (springermedizin.at)
  • Every case of monoclonal gammopathy warrants careful investigation to rule out the presence of a malignant form. (springermedizin.at)
  • Monoclonal gammopathy of undetermined significance (MGUS) is a premalignant B‑cell neoplasia usually arising from plasma cells and less frequently from lymphoplasmacytic cells. (springermedizin.at)
  • 6 As in MM, the authors observed a predominant TP expressed by many tumors PCs, but with significant single-cell diversity because most described TPs were detectable in small numbers of tumor PCs. (ashpublications.org)
  • Here, we generate dromedary camel nanobodies targeting B7-H3 and demonstrate that CAR-T cells, based on the nanobodies recognizing the IgC but not IgV domain, had potent antitumour activity against large tumors in female mice. (nature.com)
  • However, the successful application of these emerging cell-based therapies in solid tumors remains limited. (nature.com)
  • As a result, these liver organ immune system cells, including B cells and their cytokines, mainly become innate immune effectors against tumors and infections simply by their T helper-1 immune response in the liver organ. (enmd-2076.com)
  • Plasmacytic tumors make reference to several lymphoproliferative disorders seen as a monoclonal extension of plasma cells that create a one immunoglobulin molecule1 2 3 4. (siamtech.net)
  • The origin of monoclonal gammopathies is an old and never resolved debate: is it circulating postgerminal center B cells or long-lived BM-PCs? (ashpublications.org)
  • Treatment includes plasma exchange as needed for hyperviscosity and systemic therapy with alkylating drugs, corticosteroids, nucleoside analogs, Bruton's tyrosine kinase (BTK) inhibitors, venetoclax , or monoclonal antibodies. (merckmanuals.com)
  • Myeloma is cancer that develops in the plasma cells, a type of white blood cells that helps your body fight infection by producing antibodies. (gaucherdisease.org)
  • Cells were incubated with -SMA and TNFRSF1A Collagen I were visualized with an over night with specific fluorochrome main antibodies including -SMA (Abcam, Galactose 1-phosphate Potassium salt United States), Collagen I (Affinity, China) at a concentration of 1 1:100. (healthanddietblog.info)
  • These are purified antibodies cloned from a single cell. (labpedia.net)
  • Additionally, CD47 blocking antibodies inhibit proliferation of unstimulated astrocytoma cells but not normal astrocytes. (wikidoc.org)
  • In recent years, survival of MM patients has at least doubled, due to the applications of proteasome inhibitors (PI), immunomodulatory agents (IMiDs), monoclonal antibodies and stem-cell transplantation [ 2 - 4 ]. (aging-us.com)
  • Their primary function may be the production of antibodies or immunoglobulins. (siamtech.net)
  • Apoptosis is the mechanism responsible for the physiological deletion of cells and appears to be intrinsically programmed. (lookformedical.com)
  • ABT-737, a novel BH3 mimetic, was shown to block Bcl-2 and Bcl-xL and induce MM cell apoptosis. (aacrjournals.org)
  • [8] Binding of TSP-1 to CD47 influences several fundamental cellular functions including cell migration and adhesion, cell proliferation or apoptosis, and plays a role in the regulation of angiogenesis and inflammation. (wikidoc.org)
  • CD47 ligation leads to cell death in many normal and tumor cell lines via apoptosis or autophagy . (wikidoc.org)
  • The activation of CD47 induces rapid apoptosis of T cells. (wikidoc.org)
  • Jurkat cells and peripheral blood mononuclear cells ( PBMC ) incubated with the monoclonal antibody Ad22 results in apoptosis within 3 hours. (wikidoc.org)
  • Similarly, CD47 ligation rapidly induces apoptosis in B-cell chronic lymphocytic leukemia (CLL) cells. (wikidoc.org)
  • This is particularly true for galectin family members because changes in their expression levels correlate with alterations in cancer cell growth, apoptosis, and cell-cell and cell-matrix interactions. (fdocuments.net)
  • Ectopic expression of CaMKIIγ promoted cell growth, colony formation, cell cycle progress and inhibited apoptosis of MM cell lines, whereas, knockdown of CAMKIIγ expression suppressed MM cell growth in vitro and in vivo. (aging-us.com)
  • This seminal observation instigated the ensuing decades of research that characterized the complex mechanisms of intrinsic cell death and lay the foundations for the development of therapeutics capable of restoring apoptosis in malignant cells. (biomedcentral.com)
  • Methods Since different activation protocols differently affect expression and function of homing receptors, we analyzed the bone marrow homing properties and anti-tumor efficacy of NK cells stimulated in vitro with two independent protocols. (bmj.com)
  • Chimeric antigen receptor (CAR) T-cell therapy is a novel therapeutic T-cell engineering option, where T-cells obtained from a patient's blood are engineered ex vivo to express specific tumour antigen receptors. (cambridgemedicine.org)
  • In response, CAR T-cells have been designed with receptors that can proliferate and retain their function following antigen exposure (6). (cambridgemedicine.org)
  • CAR T-cells are T-cells that have been engineered to express receptors that specifically target tumour-associated antigens (8). (cambridgemedicine.org)
  • In this manner, the reduced detection of self MHC-I molecules by NK cell-inhibitory receptors coupled with an increase in activating signals by recognition of stress-induced surface ligands promote the cytolytic activity of NK cells. (biomedcentral.com)
  • High-dose melphalan followed by autologous peripheral blood stem cell transplantation may also be used. (merckmanuals.com)
  • While toxic for MM cells, the combination of GSI and ABT-737 did not affect survival of peripheral blood mononuclear cells isolated from healthy donors. (aacrjournals.org)
  • A rare, aggressive variant of MULTIPLE MYELOMA characterized by the circulation of excessive PLASMA CELLS in the peripheral blood. (lookformedical.com)
  • Chimeric antigen receptor (CAR) T-cell therapy is designed to enhance the body's immune system to effectively kill malignant cells. (ajmc.com)
  • In contrast to CD138 (the traditional plasma cell marker), CD319/SLAMF7 is much more stable and allows robust isolation of malignant plasma cells from delayed or even cryopreserved samples. (wikipedia.org)
  • Clinical features of Multiple Myeloma developed due to tissue infiltration, production of a large number of paraprotein, and impairment of immunity. (emedicodiary.com)
  • Scientists working in basic, translational, and clinical cancer metabolism research are invited to join the Academy in New York on April 17th to discuss the intersection between cell signaling and metabolism. (nyas.org)
  • AL and MM share a common causal root, namely, the presence of clonal malignant plasma cells in the bone marrow, but the behavior of these cells differ, leading to profoundly different clinical consequences. (ashpublications.org)
  • There is an unmet need to develop novel therapies for refractory/relapsed MM. In the past few years, chimeric antigen receptor (CAR)-modified T cell therapy for MM has shown promising efficacy in preclinical and clinical studies. (biomedcentral.com)
  • Bone becomes soft due to infiltration and proliferation of myeloma cells causing destruction of medullary and cortical bone and causing osteolysis due to increased osteoclastic activity by a factor released by myeloma cells). (emedicodiary.com)
  • Due to the dilutional effect of a large amount of paraprotein in circulation, depression of erythropoiesis by infiltration of myeloma cells in the bone marrow, and the effects of cytotoxic drugs. (emedicodiary.com)
  • These CAR-T cells are characterized by highly activated T cell signaling and significant tumor infiltration. (nature.com)
  • The most potent nanobody-based CAR-T cells show inhibition of large tumor xenografts in mice with rigorous T-cell signaling and significant T-cell infiltration into the tumor. (nature.com)
  • We hypothesize that inhibition of CXCR3 function on NK cells will result in increased tumor clearance, due to higher NK cell bone marrow infiltration. (bmj.com)
  • Conclusions Our results demonstrate that in vitro activation affects NK cell anti-myeloma activity in vivo by regulating their BM infiltration. (bmj.com)
  • Acute lymphoblastic leukemia (ALL): Bone marrow shows proliferation of large and heterogeneous lymphoblasts consistent with pre-B-cell ALL (French-American-British L2 morphology). (medscape.com)
  • The CD11b+ Kupffer cells producing TNF and FasL play a pivotal role in CCl4-induced acute hepatic injury thus. (enmd-2076.com)
  • Immunotherapy utilizing T cell immunity has become a new treatment to eliminate cancer cells. (biomedcentral.com)
  • abrogated antiviral immunity and stable latently infected cells represent major barriers to cure. (liverpool.ac.uk)
  • Often, the diagnosis of multiple myeloma is made incidentally during routine blood tests for other conditions. (the-medical-dictionary.com)
  • Cervical lymph node biopsy confirmed a diagnosis of multiple myeloma. (the-medical-dictionary.com)
  • An estimated 20,180 new cases of plasma cell myeloma were expected to be diagnosed in the United States in 2010, with a median age at diagnosis of 70 years. (medscape.com)
  • It is also seen more commonly in males than females but presents in a younger patient than those with plasma cell myeloma, with a median age at diagnosis of 55 years. (medscape.com)
  • The identification of oligoclonal bands in CSF is helpful in the diagnosis of multiple sclerosis . (medscape.com)
  • The paraprotein is a deviant immunoglobulin produced by the tumor clone. (the-medical-dictionary.com)
  • Additional findings are: a raised calcium (when myeloma cells are breaking down bone, releasing calcium into the bloodstream) and decreased renal function, which may be due to paraprotein deposition in the kidney). (the-medical-dictionary.com)
  • The surface antigen CD319 (SLAMF7) is a robust marker of normal plasma cells and malignant plasma cells in multiple myeloma. (wikipedia.org)
  • Antibody- and T-cell-based approaches to targeting of B-cell maturation antigen have shown efficacy. (merckmanuals.com)
  • Rational design of chimeric antigen receptor T (CAR-T) cells based on the recognition of antigenic epitopes capable of evoking the most potent CAR activation is an important objective in optimizing immune therapy. (nature.com)
  • However, there are notable challenges with CAR T-cell therapy, including non-sustained responses, antigen escape, and life-threatening adverse effects. (cambridgemedicine.org)
  • This review includes the biological basis of Chimeric Antigen Receptor (CAR) T-cell therapy as a cancer treatment modality, the opportunities and challenges that CAR T-cell therapy offers, and briefly discusses the role of natural killer (NK) cells in cancer management. (cambridgemedicine.org)
  • Recognition of antigens by T-cells is mediated by T-cell receptor (TCR), which binds to peptides presented by Major Histocompatibility Complex (MHC) found on the surface of antigen-presenting cells (6). (cambridgemedicine.org)
  • After the binding of the MHC/peptide complex to the TCR, the TCR heterodimer interacts with the antigen and facilitates clustering of the CD3 complex, which mediates further signalling that initiates T-cell activation (6). (cambridgemedicine.org)
  • CAR T-cells consist of an antigen-binding extracellular domain derived from a single chain variable segment (ScFv) of an immunoglobulin, a spacer domain, a transmembrane domain and an intracellular domain (8, 9). (cambridgemedicine.org)
  • Two main advantages of BCMA as an antigen for CAR-T therapy are the potential reduction of on-target/off-tumor toxicity and the lack of antigen-dependent reduction in CAR-T cell expansion [ 16 ]. (biomedcentral.com)
  • adoptive transfer of genetically engineered t-cells to express antigen-specific t-cell receptor (tcr) is a feasible and effective therapeutic approach for numerous types of cancers, including epstein-barr virus (ebv)-associated malignancies. (liverpool.ac.uk)
  • This stress condition can also lead to the attraction of immune cells, notably antigen presenting cells (APCs) (i.e. immature dendritic cells), natural killer cells (NK cells), and cytotoxic T-cells to the site of infection [ 5 , 6 ]. (biomedcentral.com)
  • Virus-based immunostimulatory cytokine and chemokine expression can recruit and activate T cells, antigen-presenting cells (APCs), and natural killer (NK) cells, and subsequently, improve the therapeutic activity of OVs. (biomedcentral.com)
  • However, it is also seen in plasma cell leukemia, making 3 strikingly different disorders with the same translocation. (ashpublications.org)
  • Blood cells form in the bone marrow, spongy tissue inside your bones. (gaucherdisease.org)
  • A bone marrow biopsy is usually performed to estimate the percentage of bone marrow occupied by plasma cells. (the-medical-dictionary.com)
  • Multiple myeloma (MM) [MIM:254500]: A malignant tumor of plasma cells usually arising in the bone marrow and characterized by diffuse involvement of the skeletal system, hyperglobulinemia, Bence-Jones proteinuria and anemia. (enquirebio.com)
  • Multiple myeloma (MM) is characterized by the uncontrolled proliferation of malignant plasma cells in bone marrow. (aacrjournals.org)
  • Anemia results from bone marrow replacement by plasma cell myeloma and/or the loss of erythropoietin as a result of renal injury. (medscape.com)
  • NK cell functional behavior and tumor growth were analyzed in bone marrow samples by FACS analysis. (bmj.com)
  • Results Both activation protocols promoted degranulation and IFN-γ production by donor NK cells infiltrating the bone marrow of tumor-bearing mice, although IL-15 promoted a faster but more transient acquisition of functional capacities. (bmj.com)
  • In addition, IL-15-activated cells accumulated more in the bone marrow in a short time but showed lower persistence in vivo. (bmj.com)
  • Targeting of CXCR3 increased the bone marrow homing capacity of IL-15 but not IL12/15/18 activated NK cells. (bmj.com)
  • Furthermore, we provided direct evidence that CXCR3 restrains NK cell anti-tumor capacity in vivo according to the activation protocol used, and that the effects of NK cell-based adoptive immunotherapy for multiple myeloma can be improved by increasing their bone marrow homing through CXCR3 inhibition. (bmj.com)
  • Any discrete, presumably solitary, mass of neoplastic PLASMA CELLS either in BONE MARROW or various extramedullary sites. (lookformedical.com)
  • Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. (lookformedical.com)
  • Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. (lookformedical.com)
  • These aberrant lymphoblasts proliferate, reducing the number of the normal marrow elements that produce other blood cell lines (red blood cells, platelets, and neutrophils). (medscape.com)
  • Normal plasma cells are found in the bone marrow and are an important part of the immune system. (invivoscribe.com)
  • Cells propagated in vitro in special media conducive to their growth. (lookformedical.com)
  • In this study, we first evaluated whether CAMKIIγ is dysregulated in MM patients, and how it affects MM cell function if so, we then systemically investigated the effects of berbamine and its derivative WBC158 on the growth of MM cells in vitro and in vivo. (aging-us.com)
  • Both in vitro and in vivo studies revealed that CAMKIIγ is essential for MM cell growth and berbamine analogues potently suppressed the growth of MM cells via targeting CAMKIIγ/STAT3 axis. (aging-us.com)
  • Consequently, the immune system is hyperactive, which might set it up for developing a malignant change. (gaucherdisease.org)
  • It really is today generally accepted which the livers of mice and human beings contain types of innate immune system cells [11]C[13]. (enmd-2076.com)
  • In 1959, Lewis Thomas suggested that the human immune system can recognise tumour-specific antigens on the surface of newly developing tumour cells as 'foreign' and eliminate them (3). (cambridgemedicine.org)
  • The immune system interacts closely with tumour cells via complex mechanisms and can result in either eradication of the tumour or immune evasion by the tumour (5). (cambridgemedicine.org)
  • Generally, CD8 + cytotoxic T-cells and CD4 + helper T-cells, which belong to the adaptive immune system, control the development of cancer via mechanisms like the production of pro-inflammatory cytokines (eg. (cambridgemedicine.org)
  • It really is represented with a solitary ORY-1001(trans) osteolytic lesion without systemic manifestations of multiple myeloma, and includes a favorable prognosis after treatment therefore. (siamtech.net)
  • latent infection can spread by b cell recirculation and proliferation, but whether this alone achieves systemic infection is unclear. (liverpool.ac.uk)
  • The CD47/SIRPα interaction leads to bidirectional signaling, resulting in different cell-to-cell responses including inhibition of phagocytosis , stimulation of cell-cell fusion, and T-cell activation . (wikidoc.org)
  • Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. (lookformedical.com)
  • Signaling through the receptor/transcriptional regulator Notch plays an important role in tumor cell survival. (aacrjournals.org)
  • CD47 is a high affinity receptor for thrombospondin-1 (TSP-1), a secreted glycoprotein that plays a role in vascular development and angiogenesis, and in this later capacity the TSP1-CD47 interaction inhibits nitric oxide signaling at multiple levels in vascular cells. (wikidoc.org)
  • The intracellular domain of the receptor distinguishes the different CAR T-cell generations as shown in Figure 1. (cambridgemedicine.org)
  • It is closely associated with B cell-activating factor of the TNF family (BAFF) receptor, transmembrane activator, calcium modulator, and cyclophilin ligand interactor (TACI) [ 14 ]. (biomedcentral.com)
  • First-generation CAR T-cells consist only of the TCR-derived CD3ζ intracellular signalling domain, which induces T-cell activation as illustrated in Figure 1 (6, 8). (cambridgemedicine.org)
  • While effective, broad use of CAR T-cell therapies is limited by potential for life-threatening toxicities, challenges related to manufacturing a patient-specific product, high costs and inadequate reimbursement, and incomplete or unsustained disease response. (ajmc.com)
  • CAR T-cell therapies are limited by the potential to cause life-threatening toxicities, including cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS). (ajmc.com)
  • The integrated stress response is a signaling pathway activated in cancer cells in response to both dysregulated growth and metabolism, and also following exposure to many therapies that appears one such targetable pathway for improved treatment of these diseases. (biomedcentral.com)
  • Targeted therapies exploit molecular vulnerabilities unique to cancer cells and typically alter cellular signaling pathways to inhibit tumorigenic growth and promote cell death. (biomedcentral.com)
  • MGUS has an overall low risk of progression to multiple myeloma (MM) or other associated diseases. (springermedizin.at)
  • Depending on the immunoglobulin subtype, the rate of progression can vary from 0.3% per year in light-chain MGUS to 1.5% in IgM MGUS. (springermedizin.at)
  • Activation of CCND1 may be oncogenic by directly altering progression through the cell cycle. (enquirebio.com)
  • After considerable washing with PBS, cells were incubated with goat Alexa Fluor 488-labeled secondary antibody (Existence Technologies, United States) for 1?h at space temperature and nuclei were stained with DAPI. (healthanddietblog.info)
  • One emerging treatment option for several antibody-mediated autoimmune diseases is the anti-CD38 antibody daratumumab, which depletes autoantibody-secreting plasma cells. (bmj.com)
  • Autoimmune pancreatitis (AIP) is now considered a pancreatic manifestation of a newly proposed disease condition, IgG4-related disease (IgG4-RD). IgG4-RD is characterized by enhanced IgG4 antibody responses and multiple organ involvements. (go.jp)